APA (7th ed.) Citation

D, L., M, W., FA, S., B, M., J, M., KA, D., . . . NA, B. (2026). Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancer. Therapeutic advances in medical oncology, 18, 17588359251409010. https://doi.org/10.1177/17588359251409010

Chicago Style (17th ed.) Citation

D, Liu, et al. "Repurposing of Ivacaftor Shows Potential to Treat ROR1 Expressing High-grade Serous Ovarian Cancer." Therapeutic Advances in Medical Oncology 18 (2026): 17588359251409010. https://doi.org/10.1177/17588359251409010.

MLA (9th ed.) Citation

D, Liu, et al. "Repurposing of Ivacaftor Shows Potential to Treat ROR1 Expressing High-grade Serous Ovarian Cancer." Therapeutic Advances in Medical Oncology, vol. 18, 2026, p. 17588359251409010, https://doi.org/10.1177/17588359251409010.